Taysha Gene Therapies
TSHA
#7252
Rank
S$0.47 B
Marketcap
$2.31
Share price
-3.30%
Change (1 day)
-25.96%
Change (1 year)

Taysha Gene Therapies (TSHA) - Cash on Hand

Cash on Hand as of December 2024 : S$0.18 Billion

According to Taysha Gene Therapies's latest financial reports the company has S$0.18 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Taysha Gene Therapies - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.18 B-0.59%
2023-12-31S$0.19 B61.36%
2022-12-31S$0.11 B-41.55%
2021-12-31S$0.20 B-39.36%
2020-12-31S$0.33 B
2019-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.33 B 84.10%๐Ÿ‡บ๐Ÿ‡ธ USA